The regulation of protein translation and its implications for cancer

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• Aberrant protein translation from mRNAs is crucial in cancer development.
• Existing cancer therapies focus on gene transcription and protein modification, but translation is also a key target.
• Emerging research highlights the role of mRNA modifications and noncoding RNAs in regulating protein translation.

Purpose of the Study:

• To review recent advancements in understanding how mRNA modifications and noncoding RNAs interact to regulate protein translation.
• To explore the implications of these regulatory mechanisms in cancer pathogenesis.
• To provide insights for developing novel precision cancer therapies targeting mRNA translation.

Main Methods:

• Literature review of recent studies on mRNA modifications (e.g., N6-methyladenine [m⁶A]) and noncoding RNAs (microRNAs, long noncoding RNAs).
• Analysis of the interplay between these regulatory factors in protein translation.
• Synthesis of findings related to cancer pathogenesis and therapeutic potential.

Main Results:

• mRNA modifications, particularly m⁶A, and various ncRNAs significantly impact protein translation.
• The complex interplay between mRNA modifications and ncRNAs influences translation initiation and efficiency.
• Dysregulation of these translational control mechanisms contributes to cancer progression.

Conclusions:

• Targeting mRNA translation, through modulation of mRNA modifications and ncRNAs, presents a promising avenue for anticancer drug development.
• Understanding the intricate network of translational regulation is key to advancing precision oncology.
• This review offers a foundation for future research into novel therapeutic strategies for human cancers.